Progression of noncirrhotic portal hypertension in a pediatric population

Brandon M Wojcik1, Sarwar Zahid1, Shijie Cai1

  • 1Michigan Academic Surgery Interest Group, Department of Surgery, University of Michigan, Ann Arbor, MI, USA.

Insights

Pediatric noncirrhotic portal hypertension management is debated. This study suggests most children achieve good long-term outcomes with conservative care, avoiding surgery.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Surgical Management

Background:

  • Management of noncirrhotic portal hypertension in children lacks consensus.
  • Surgical intervention versus conservative approaches are debated.

Purpose of the Study:

  • To evaluate long-term outcomes of pediatric noncirrhotic portal hypertension.
  • Compare outcomes between surgical and conservative management strategies.

Main Methods:

  • Retrospective study of 26 pediatric patients.
  • Analysis of platelet counts, WBC counts, spleen size, hospital admissions, and GI bleeds.
  • Utilized univariate and time-trend analyses.

Main Results:

  • Portal vein thrombosis present in 84.6% of patients.
  • No progression of hypersplenism in non-surgical patients; no significant spleen size reduction post-surgery.
  • Surgical intervention significantly reduced GI bleeding hospital admissions (P=0.0009).
  • Platelet and WBC counts trended downward in medically managed patients; increased/stable in surgical patients.

Conclusions:

  • Most pediatric noncirrhotic portal hypertension patients may achieve good long-term outcomes without surgery.
  • Findings suggest conservative management can be effective, despite study limitations.
Abstract

Related Concept Videos

Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
2.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
362
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
825
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
863
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
8.4K